Meeting
2024 ASCO Genitourinary Cancers Symposium
Initial screening efforts for the OPTIC RCC trial.
Authors
Scott Mattox Haake
Vanderbilt University Medical Center, Nashville, TN
Scott Mattox Haake , Katy Beckermann , Yu-Wei Chen , Anupama Reddy , Nataliya Mar , Moshe Chaim Ornstein , Pedro C. Barata , Tian Zhang , Sumanta Kumar Pal , W. Kimryn Rathmell , Brian I. Rini
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
NCT05361720
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 478)
DOI
10.1200/JCO.2024.42.4_suppl.478
Abstract #
478
Poster Bd #
K19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Biomarker-driven prospective clinical trial in renal cell carcinoma: Developing machine learning models to allocate patients to treatment arms using RNA sequencing.
First Author: Anupama Reddy
Poster
2023 ASCO Genitourinary Cancers Symposium
Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC).
First Author: Yu-Wei Chen
Poster
2020 ASCO Virtual Scientific Program
Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens.
First Author: Di Ran
Poster
2019 ASCO Annual Meeting
Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma.
First Author: Ritesh Kotecha